
Yvonne Y. Chan
· M.D.VerifiedUniversity of California, Davis · Urology
Active 2012–2025
About
Yvonne Y. Chan, M.D., is an Assistant Professor specializing in Pediatric Urology at UC Davis Health. She has a passion for caring for children with a broad range of urologic conditions and seeks to incorporate her interest in quality improvement into her clinical care to enhance patient outcomes. Her clinical interests include spina bifida, minimally invasive surgery, hypospadias, vesicoureteral reflux, and complex urologic construction. Dr. Chan believes that every child deserves the chance to be a kid and emphasizes clear communication and shared decision making with patients and their families to ensure they thoroughly understand their conditions and management options. She aims to support patients with congenital urologic conditions requiring lifelong medical attention, helping them understand their conditions and how to care for themselves as they approach early adulthood, while also providing medical or surgical interventions to improve their quality of life. Her research interests include patient safety and quality improvement, post-surgical outcomes, and medical education. She has implemented enhanced recovery protocols for children with spina bifida undergoing bladder reconstruction to improve their post-operative recoveries. Dr. Chan is active in simulation design and in improving urologic surgical education for residents, reflecting her commitment to advancing both clinical practice and training in pediatric urology.
Research topics
- Medicine
- Surgery
- Urology
- Biomedical engineering
- Developmental psychology
- General surgery
- Andrology
- Medical physics
- Psychology
- Biology
- Cell biology
- Operations management
- Pathology
Selected publications
Ambulatory status and sexual function and activity in young adults with spina bifida
Journal of Pediatric Urology · 2025-01-30 · 2 citations
articleJournal of Pediatric Urology · 2025-03-01
articleOpen accessJournal of Pediatric Urology · 2025-06-25 · 3 citations
articlePNAS Nexus · 2024-01-30 · 9 citations
articleOpen accessAbstract To date, there are no efficacious translational solutions for end-stage urinary bladder dysfunction. Current surgical strategies, including urinary diversion and bladder augmentation enterocystoplasty (BAE), utilize autologous intestinal segments (e.g. ileum) to increase bladder capacity to protect renal function. Considered the standard of care, BAE is fraught with numerous short- and long-term clinical complications. Previous clinical trials employing tissue engineering approaches for bladder tissue regeneration have also been unable to translate bench-top findings into clinical practice. Major obstacles still persist that need to be overcome in order to advance tissue-engineered products into the clinical arena. These include scaffold/bladder incongruencies, the acquisition and utility of appropriate cells for anatomic and physiologic tissue recapitulation, and the choice of an appropriate animal model for testing. In this study, we demonstrate that the elastomeric, bladder biomechanocompatible poly(1,8-octamethylene-citrate-co-octanol) (PRS; synthetic) scaffold coseeded with autologous bone marrow-derived mesenchymal stem cells and CD34+ hematopoietic stem/progenitor cells support robust long-term, functional bladder tissue regeneration within the context of a clinically relevant baboon bladder augmentation model simulating bladder trauma. Partially cystectomized baboons were independently augmented with either autologous ileum or stem-cell-seeded small-intestinal submucosa (SIS; a commercially available biological scaffold) or PRS grafts. Stem-cell synergism promoted functional trilayer bladder tissue regeneration, including whole-graft neurovascularization, in both cell-seeded grafts. However, PRS-augmented animals demonstrated fewer clinical complications and more advantageous tissue characterization metrics compared to ileum and SIS-augmented animals. Two-year study data demonstrate that PRS/stem-cell-seeded grafts drive bladder tissue regeneration and are a suitable alternative to BAE.
Journal of Pediatric Urology · 2024-05-23
letterEmergent robot-to-open conversion – Multidisciplinary simulation training in crisis management
Journal of Pediatric Urology · 2024-06-15 · 6 citations
review1st authorCorrespondingJournal of Pediatric Urology · 2024-07-16
letter1st authorCorrespondingJournal of Pediatric Urology · 2023-05-05 · 3 citations
articleJournal of Pediatric Urology · 2023-12-30 · 8 citations
articleOpen accessJournal of Pediatric Urology · 2023-06-02 · 5 citations
article
Frequent coauthors
- 31 shared
Eric A. Kurzrock
- 19 shared
David I. Chu
Lurie Children's Hospital
- 15 shared
Arun K. Sharma
- 15 shared
Earl Y. Cheng
Northwestern University
- 14 shared
Craig A. Peters
Children's Medical Center
- 14 shared
Ilina Rosoklija
Lurie Children's Hospital
- 14 shared
Elizabeth B. Yerkes
- 12 shared
Edward M. Gong
Lurie Children's Hospital
Education
- 2018
Resident, Urology
UC Davis Health System
- 2012
M.D.
David Geffen School of Medicine at UCLA
- 2008
B.S., Biology
Stanford University
Awards & honors
- Recipient of the Armstrong Endowment for Compassionate Care,…
- Provider of the Month Outpatient Clinics (2020)
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Yvonne Y. Chan
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup